| 000 | 01629 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517145306.0 | ||
| 264 | 0 | _c20180618 | |
| 008 | 201806s 0 0 eng d | ||
| 022 | _a2405-4577 | ||
| 024 | 7 |
_a10.1016/j.clnesp.2016.10.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKawai, Keisuke | |
| 245 | 0 | 0 |
_aGhrelin activation and neuropeptide Y elevation in response to medium chain triglyceride administration in anorexia nervosa patients. _h[electronic resource] |
| 260 |
_bClinical nutrition ESPEN _cFeb 2017 |
||
| 300 |
_a100-104 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnorexia Nervosa _xblood |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aBody Composition |
| 650 | 0 | 4 |
_aEnteral Nutrition _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGhrelin _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aJapan |
| 650 | 0 | 4 |
_aNeuropeptide Y _xblood |
| 650 | 0 | 4 | _aNutrition Assessment |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTriglycerides _xadministration & dosage |
| 650 | 0 | 4 | _aUp-Regulation |
| 650 | 0 | 4 | _aWeight Gain |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aNakashima, Megumi | |
| 700 | 1 | _aKojima, Masayasu | |
| 700 | 1 | _aYamashita, Sakino | |
| 700 | 1 | _aTakakura, Shu | |
| 700 | 1 | _aShimizu, Miki | |
| 700 | 1 | _aKubo, Chiharu | |
| 700 | 1 | _aSudo, Nobuyuki | |
| 773 | 0 |
_tClinical nutrition ESPEN _gvol. 17 _gp. 100-104 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clnesp.2016.10.001 _zAvailable from publisher's website |
| 999 |
_c27034407 _d27034407 |
||